Cinclus Pharma has chosen Advantum as a service to ensure quality and streamline its document management. With Advantum as a service, Cinclus Pharma subscribes to a modern web-based environment with very high security. Thanks to Advantum's service solution, Cinclus Pharma does not need to make any own investment in hardware and licenses. With Advantum, Cinclus Pharma receives powerful system support for creating, maintaining and archiving documentation throughout the entire process.
Cinclus Pharma is a Swedish clinical-stage pharmaceutical company developing molecules for the treatment of acid-related diseases. Their lead drug candidate linaprazan glurate is being developed for the treatment of severe gastroesophageal reflux disease (GERD).
Read more about Advantum here.
Read more about Cinclus Pharma here.
For more information please contact:
Christina Hall
InfoTech Scandinavia AB
christina.hall@infotech.se
+46 709 67 00 15
